Search Results - "Samudio, Ismael J"
-
1
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
Published in Blood (11-06-2009)“…SDF-1α/CXCR4 signaling plays a key role in leukemia/bone marrow microenvironment interactions. We previously reported that bone marrow–derived stromal cells…”
Get full text
Journal Article -
2
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Published in Blood (15-04-2007)“…The mTOR complex 2 (mTORC2) containing mTOR and rictor is thought to be rapamycin insensitive and was recently shown to regulate the prosurvival kinase AKT by…”
Get full text
Journal Article -
3
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
Published in Molecular cancer therapeutics (01-12-2006)“…The chemokine receptor CXCR4 mediates the migration of hematopoietic cells to the stroma-derived factor 1α (SDF-1α)–producing bone marrow microenvironment…”
Get full text
Journal Article -
4
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
Published in Blood (01-11-2005)“…Although TP53 mutations are rare in acute myeloid leukemia (AML), inactivation of wild-type p53 protein frequently occurs through overexpression of its…”
Get full text
Journal Article -
5
Effects of the breed, sex and age on cellular content and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel
Published in BMC veterinary research (12-02-2013)“…There is no information on the effects of the breed, gender and age on the cellular content and growth factor (GF) release from equine pure-platelet rich…”
Get full text
Journal Article -
6
Concomitant Inhibition of MDM2 and Bcl-2 Protein Function Synergistically Induce Mitochondrial Apoptosis in AML
Published in Cell cycle (Georgetown, Tex.) (01-12-2006)“…Disruption of Mdm2-p53 interaction activates p53 signaling, disrupts the balance ofantiapoptotic and proapoptotic Bcl-2 family proteins and induces apoptosis…”
Get full text
Journal Article -
7
Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells
Published in Cancer research (Chicago, Ill.) (01-04-2007)“…Activation of the Raf/MEK/ERK pathway and inactivation of wild-type p53 by Mdm2 overexpression are frequent molecular events in acute myelogenous leukemia…”
Get full text
Journal Article -
8
Simultaneous inhibition of PDK1/AKT and fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia
Published in Cancer research (Chicago, Ill.) (01-04-2006)“…Phosphoinositol-3-kinase (PI3K)/protein kinase B (AKT) and Fms-like tyrosine kinase 3 (FLT3) signaling are aberrantly activated in acute myelogenous leukemia…”
Get full text
Journal Article -
9
Effects over time of two platelet gel supernatants on growth factor, cytokine and hyaluronan concentrations in normal synovial membrane explants challenged with lipopolysaccharide
Published in BMC musculoskeletal disorders (20-06-2015)“…Platelet-rich plasma (PRP) preparations are a common treatment in osteoarthritis (OA) and inflammatory synovitis. However, there is ambiguity regarding the…”
Get full text
Journal Article -
10
A novel ring-substituted diindolylmethane, 1,1-bis[3'-(5-Methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia
Published in Cancer research (Chicago, Ill.) (01-04-2005)“…We investigated the antileukemic activity and molecular mechanisms of action of a newly synthesized ring-substituted diindolylmethane derivative,…”
Get full text
Journal Article -
11
Autologous Platelet Concentrates as an Adjunctive Treatment for Chronic Laminitis in a Mare with Pituitary Pars Intermedia Dysfunction
Published in Journal of equine veterinary science (01-03-2013)“…The aim of this article was to describe a case of a 7-year-old mare with chronic laminitis secondary to pituitary pars intermedia dysfunction that was…”
Get full text
Journal Article -
12
Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells
Published in Leukemia & lymphoma (01-05-2010)“…Non-mutational inactivation of p53 is frequent in acute myeloid leukemia (AML) via overexpression of MDM2. We report that treatment with MI-63, a novel…”
Get full text
Journal Article -
13
HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML
Published in Leukemia (01-06-2013)“…Nur77 and Nor1 are highly conserved orphan nuclear receptors. We have recently reported that nur77 −/− nor1 −/− mice rapidly develop acute myeloid leukemia…”
Get full text
Journal Article -
14
Synergistic Activation of p53 Family of Proteins by the Combination of Nutlin 3a and SAHA in Acute Myelogenous Leukemia
Published in Blood (20-11-2009)“…Abstract 1738 Poster Board I-764 Nutlin 3a binds to murine double minute 2 (MDM2) a negative regulator of p53 and potently increases p53 protein levels by…”
Get full text
Journal Article -
15
Pharmacological Inhibition of Fatty Acid Oxidation as a Novel Therapeutic Concept for Acute Myeloid Leukemia
Published in Blood (20-11-2009)“…Abstract 3779 Poster Board III-715 Otto Warburg proposed that the origin of cancer cells was closely linked to a permanent respiratory defect that bypassed the…”
Get full text
Journal Article -
16
CXCR4 Expression and Biological Activity Is Dependent on Oxygen Partial Pressure in Acute Myeloid Leukemia
Published in Blood (16-11-2008)“…CXCR4, the receptor for bone marrow stroma derived SDF-1, has recently been studied in normal hematopoiesis and hematologic malignancies. Increased expression…”
Get full text
Journal Article -
17
Targeting Anaplerotic Pathways That Support Fatty Acid Metabolism as a Therapeutic Strategy for Hematological Malignancies: The Achilles' Heel of the Warburg Effect
Published in Blood (16-11-2008)“…More than half a century ago, Otto Warburg proposed that the origin of cancer cells was closely linked to a permanent respiratory defect that bypassed the…”
Get full text
Journal Article -
18
Targeting the Hypoxic Microenvironment by mTOR Inhibitors Sensitizes ALL Cells to Chemotherapy
Published in Blood (16-11-2008)“…The main therapeutic challenge in the treatment of Acute Lymphocytic Leukemia (ALL) is the development of strategies aimed at overcoming resistance to…”
Get full text
Journal Article -
19
Apoptosis Inducing Factor Acts as a Survival Factor in Acute Myelogenous Leukemia through Mitochondrial Complex 1
Published in Blood (16-11-2007)“…Apoptosis inducing factor (AIF) is a mitochondrial flavoprotein that is released into the cytoplasm to form an active DNase and then translocates into the…”
Get full text
Journal Article -
20
Activation of p53 signaling by MI-63 induces apoptosis in acute myelogenous leukemia cells
Published in Leukemia & lymphoma (01-05-2010)“…Non-mutational inactivation of p53 is frequent in acute myeloid leukemia (AML) via overexpression of MDM2. We report that treatment with MI-63, a novel…”
Get full text
Journal Article